NCT Number: NCT00230308
Through this study, we hope to learn more about the mechanisms, which may contribute to development and progression of head and neck cancer. The long-term goal of this study will be to develop new strategies and drugs for the diagnosis and treatment of head and neck cancer.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Stanford, California, 94305, United States
Location status: Recruiting
Cancer Clinical Trials Office
CONTACT
Dr Michael Kaplan
SUB_INVESTIGATOR
Jan Matthijs van de Rijn
SUB_INVESTIGATOR
John B Sunwoo
PRINCIPAL_INVESTIGATOR
Nikita Bedi
CONTACT
Quynh-Thu Le
SUB_INVESTIGATOR
Willard E Fee Jr
SUB_INVESTIGATOR
Zijie Sun
SUB_INVESTIGATOR
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
All patients undergoing surgery at Stanford University for head and neck cancer.
Exclusion criteria
Non-Stanford patients.
Contact information is provided by the study sponsor or research team.
Stanford University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06970275
Breast Cancer, Breast Diseases
Ghent, Belgium
View Trial DetailsNCT07726407
Head and Neck Cancer, Head and Neck Neoplasms
Guangzhou, Guangdong, China
View Trial DetailsNCT07124000
Adenocarcinoma, Adenocarcinoma (NOS)
Birmingham, Alabama, United States
View Trial DetailsNCT07090499
Adenocarcinoma, Adenocarcinoma Of Esophagus
Duarte, California, United States
View Trial Details